CleanCap® - optimized co-transcriptional capping for vaccine and therapeutic applications.
Achieve optimal capping results.
Learn More
Our new facility expansion will enable TriLink to offer custom plasmid DNA production services, as well as enhanced scale-up manufacturing of CleanCap® mRNA capping solutions and small molecules.
Learn moreCleanCap® mRNA for rapid vaccine development and top-tier oligos to power diagnostic kits
Contact Us for Immediate ResponseFind out how CleanCap® technology reduces cost while increasing efficiency.
Learn MoreTriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its proprietary CleanCap® mRNA capping technology. TriLink continues to expand its cGMP and general mRNA, oligonucleotide & plasmid manufacturing capacity at its new global headquarters to support therapeutic, vaccine and diagnostic customers.
Achieve optimal capping results.
Learn More
November 24, 2020 - January 31, 2021
Robust service offerings, with the phases and support you need to see your project to completion.
Learn MoreHow Pigs Perform Lung Pathogen Clearance
Learn MoreUnderstanding Cellular Spatial Organization in Colorectal Cancer
Learn MoreAn Evolutionary Examination of PCIF1 and m6Am in RNA Cap Structure
Learn MoreThe TriLink Education Center is an innovation resource hub. Read the latest in technical articles, research updates, publications, and more.
Learn More
Loading...